D-0512-2026 Class II Ongoing

Recalled by Fresenius Medical Care Holdings, Inc. — Waltham, MA

FDA drug recall D-0512-2026 was initiated by Fresenius Medical Care Holdings, Inc. on Apr 6, 2026 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Potential leaks from perforations in bags. The recall status is ongoing. Affected quantity: 37,215 bags.

Recall details

Product Type
Drugs
Report Date
May 13, 2026
Initiation Date
Apr 6, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
37,215 bags

Product description

DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 1.5% DEX. LM/LC, 2L 5PK, Part Number 054-20221, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451.

Reason for recall

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Distribution pattern

Nationwide in the USA

Code information

Lot #: 25CU02007, 25CU02008, 25CU02009

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0512-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0512-2026. Report a data issue: hello@regdatalab.com.